Published in TB and Outbreaks Week, February 1st, 2000
"We confirm that increasing doses of Flt-3L, administered subcutaneously to mice for 9 consecutive days, caused a corresponding increase in total spleen cell number," Smith et al. wrote in a study titled "Effect of Flt-3 ligand on HSV-1 pathogenesis," presented at the Joint Congress of the British Society for Immunology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week